American Statistical Association
Advances in cancer diagnostic and treatment development over the past decade have created an unprecedented need for high quality evidence to guide oncologist and regulator decision making. Whereas prospective randomized clinical trials remain the gold standard for evidence development, this evidence gap demands consideration of other data sources to support therapeutic development and patient care. The ubiquity of electronic health records raises the potential for data obtained during the routine care of cancer patients to be used for hypothesis-testing. Dr. Meropol will discuss the challenges and opportunities for use of real-world evidence in oncology, and will present examples of where it may have greatest impact.
|Date:||Wednesday, October 17, 2018|
|Time:||4:00 - 5:00 P.M.|
Memorial Sloan Kettering Cancer Center
Department of Epidemiology and Biostatistics
485 Lexington Avenue
(Between 46th & 47th Streets)
2nd Floor, Conference Room B
New York, New York
**Outside visitors please email email@example.com for building access.
You must be on the security list to enter the floor.